Gout Flare and Cardiovascular Events-Reply.

JAMA

Academic Rheumatology, University of Nottingham, Nottingham, United Kingdom.

Published: January 2023

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2022.20114DOI Listing

Publication Analysis

Top Keywords

gout flare
4
flare cardiovascular
4
cardiovascular events-reply
4
gout
1
cardiovascular
1
events-reply
1

Similar Publications

Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications.

J Clin Med

December 2024

Department of Rheumatology, Päijät-Häme Central Hospital, Wellbeing Services County of Päijät-Häme, 15850 Lahti, Finland.

Gout is the most common form of inflammatory arthritis, caused by the deposition of monosodium urate crystals in the joints due to elevated serum uric acid levels. Its prevalence and associated healthcare burden have been rising in recent decades, a trend expected to continue. It is crucial to recognize that gout and hyperuricemia are not merely causes of painful joint flares, but systemic metabolic disorders linked to a broad spectrum of comorbidities such as cardiovascular diseases, chronic kidney disease, diabetes, insulin resistance, steatotic liver disease, osteoarthritis, and respiratory and eye diseases.

View Article and Find Full Text PDF

Gout, a common chronic disease, is characterized by the formation and deposition of monosodium urate (MSU) crystal deposition in articular and nonarticular structures. Osteoarthritis (OA), the most prevalent type of arthritis, is a progressive degenerative joint disease. Previous clinical studies have reported that gout frequently affects OA joints; however, the underlying mechanism remains unidentified.

View Article and Find Full Text PDF
Article Synopsis
  • Gout flares are crucial indicators of the disease's impact, with specific maximum flare counts linked to acceptable symptom states (PASS) and low disease activity (LDA).
  • A study analyzed data from 179 gout patients over 12 months, focusing on flare occurrences and assessing their impact on patient-reported outcomes, including quality of life and illness perception.
  • Results showed that while many participants achieved either PASS or LDA, increased flare frequency correlated with higher negative impacts on patients, emphasizing the need for effective flare prevention strategies in gout management.
View Article and Find Full Text PDF

Purpose: Previous studies have linked high-density lipoprotein cholesterol (HDL-C) to gout, but little is known about the dose-effect relationship between serum HDL-C levels and gout flares. This study aimed to quantify the association between the two during urate-lowering therapy initiation and develop a regression equation to predict gout flares.

Patients And Methods: We conducted a prospective, observational, single-center cohort study of men with gout.

View Article and Find Full Text PDF

Refractory Tophaceous Gout With Psoriatic Arthritis: A Case Report.

Cureus

November 2024

Internal Medicine, Unidade Local de Saúde de Santo António, Porto, PRT.

Although gout is a common intermittent crystalline arthropathy, tophaceous gout is a rare condition. Flares of this disease are usually treated with anti-inflammatory drugs followed by control of serum uric acid levels. We present a refractory, severe, tophaceous gout overlapping with psoriatic arthritis, presenting with a hyper-inflamed phenotype resistant to conventional anti-inflammatory and hypouricemic agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!